Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation.
hospital
medication systems
pharmacy service
quality of health care
safety
total quality management
Journal
European journal of hospital pharmacy : science and practice
ISSN: 2047-9956
Titre abrégé: Eur J Hosp Pharm
Pays: England
ID NLM: 101578294
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
14
09
2020
revised:
08
02
2021
accepted:
15
02
2021
pubmed:
18
3
2021
medline:
2
4
2022
entrez:
17
3
2021
Statut:
ppublish
Résumé
Documented experiences of relocating hospital pharmacies are rare, but adequate preparation is vital to ensuring smooth pharmacy operation and patient safety. In the autumn of 2019, the Pharmacy of Eastern Vaud Hospitals, composed of four units (Logistics, Manufacturing, Clinical Pharmacy, and Nursing Home Supply), was relocated to a new hospital in just a few days. In this context, a failure modes, effects and criticality analysis (FMECA) was carried out before the relocation in order to anticipate any failure modes likely to affect the pharmacy's missions or patient safety during the move. The FMECA was performed by a multidisciplinary team (pharmacists and logisticians) which analysed the complete upcoming process of relocating the pharmacy and its implications. Criticality indices (CIs) were defined based on the matrix developed by Williams The analysis identified 86 potential failures. The mean initial CI calculated for the entire pharmacy relocation was 177 (min 4-max 567), but this was estimated to be reduced to 39 (-78%) after mitigation measures were identified. Within the whole pharmacy, the failures with the highest CIs were identified in the Logistics unit. Among these, the time necessary to transfer the pharmacy's drugs from their traditional alphabetical storage location to their new location using robotic, chaotic storage principles was identified as the riskiest potential failure. Indeed, the rapid availability of emergency medicines would have to be guaranteed at all times. The present study highlighted the relevance of using an FMECA-type evaluation to anticipate the impact of a hospital pharmacy relocation. This tool enabled pharmacy professionals to structure their potential relocation problems and reflect on mitigation measures in order to provide concerted, realistically applicable solutions before the move.
Identifiants
pubmed: 33727217
pii: ejhpharm-2020-002525
doi: 10.1136/ejhpharm-2020-002525
pmc: PMC8640422
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e164-e170Informations de copyright
© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Eval Clin Pract. 2015 Aug;21(4):549-59
pubmed: 25847021
Can J Hosp Pharm. 2018 Nov-Dec;71(6):376-384
pubmed: 30626984
Pharm Times. 1980 Aug;46(8):90-3
pubmed: 10248166
Hosp Pediatr. 2018 Mar;8(3):148-156
pubmed: 29449317
J Nurs Adm. 2014 Oct;44(10):535-40
pubmed: 25280076
Hosp Pharm. 1994 Apr;29(4):331-2, 334-6, 339
pubmed: 10133462
J Intensive Care Soc. 2016 Nov;17(4):326-331
pubmed: 28979517
Aust Health Rev. 2002;25(2):155-61
pubmed: 12046143
BMJ Qual Saf. 2013 Jan;22(1):42-52
pubmed: 22976504
Prehosp Disaster Med. 2017 Jun;32(3):321-328
pubmed: 28300525
Crit Care Nurs Q. 2017 Jan/Mar;40(1):59-66
pubmed: 27893510
Int J Qual Health Care. 2006 Feb;18(1):9-16
pubmed: 16275659
Int J Occup Saf Ergon. 2017 Dec;23(4):589-591
pubmed: 27935431
Arch Surg. 2009 Sep;144(9):859-64
pubmed: 19797112
Top Hosp Pharm Manage. 1983 Aug;3(2):17-26
pubmed: 10314019
J Inj Violence Res. 2017 Jan 01;9(1):
pubmed: 28039688
Aust Crit Care. 2016 May;29(2):55-60
pubmed: 26602862